{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:28:48Z","timestamp":1762032528652},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1007\/bf01709586","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T09:33:40Z","timestamp":1118914420000},"page":"228-232","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the E test for fluconazole susceptibility testing ofCandida albicans isolates from oropharyngeal candidiasis"],"prefix":"10.1007","volume":"16","author":[{"given":"E.","family":"Dannaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pichot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Piens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01709586_CR1","first-page":"1405","volume-title":"Manual of clinical microbiology","author":"A Espinel-Ingroff","year":"1995","unstructured":"Espinel-Ingroff A, Pfaller MA: Antifungal agents and susceptibility testing. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1995, p. 1405\u20131414."},{"key":"BF01709586_CR2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P","author":"National Committee for Clinical Laboratory Standards","year":"1992","unstructured":"National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. NCCLS, Villanova, PA, 1992."},{"key":"BF01709586_CR3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.29.6.1089-1094.1991","volume":"29","author":"A Espinel-Ingroff","year":"1991","unstructured":"Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S: Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 1991, 29: 1089\u20131094.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0738-1751(92)90015-3","volume":"8","author":"ML Sanchez","year":"1992","unstructured":"Sanchez ML, Jones RN: E test, an antimicrobial susceptibility testing method with broad clinical and epidemiologic application. Antimicrobic Newsletter 1992, 8: 1\u20138.","journal-title":"Antimicrobic Newsletter"},{"key":"BF01709586_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0732-8893(94)90034-5","volume":"19","author":"A Espinel-Ingroff","year":"1994","unstructured":"Espinel-Ingroff A: E test for antifungal susceptibility testing of yeasts. Diagnostic Microbiology and Infectious Disease 1994, 19: 217\u2013220.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"BF01709586_CR6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/JCM.32.9.2099-2102.1994","volume":"32","author":"DL Sewell","year":"1994","unstructured":"Sewell DL, Pfaller MA, Barry AL: Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. Journal of Clinical Microbiology 1994, 32: 2099\u20132102.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.33.3.535-540.1995","volume":"33","author":"AL Colombo","year":"1995","unstructured":"Colombo AL, Barchiesi F, McGough DA, Rinaldi MG: Comparison of E test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. Journal of Clinical Microbiology 1995, 33: 535\u2013540.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR8","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/AAC.39.11.2520","volume":"39","author":"A Wanger","year":"1995","unstructured":"Wanger A, Mills K, Nelson PW, Rex JH: Comparison of E test and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistantCandida isolates. Antimicrobial Agents and Chemotherapy 1995, 39: 2520\u20132522.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01709586_CR9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/JCM.34.4.848-852.1996","volume":"34","author":"A Espinel-Ingroff","year":"1996","unstructured":"Espinel-Ingroff A, Pfaller MA, Erwin ME, Jones RN: Interlaboratory evaluation of E test method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. Journal of Clinical Microbiology 1996, 34: 848\u2013852.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR10","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/JCM.34.7.1691-1693.1996","volume":"34","author":"MA Pfaller","year":"1996","unstructured":"Pfaller MA, Messer SA, Bolmstr\u00f6m A, Odds FC, Rex JH: Multisite reproducibility of the E test MIC method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 1996, 34: 1691\u20131693.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/JCM.34.4.842-847.1996","volume":"34","author":"J Eldere Van","year":"1996","unstructured":"Van Eldere J, Joosten L, Verhaeghe A, Surmont I: Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E test and semiautomated broth microdilution test. Journal of Clinical Microbiology 1996, 34: 842\u2013847.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","volume":"39","author":"JH Rex","year":"1995","unstructured":"Rex JH, Rinaldi MG, Pfaller MA: Resistance ofCandida species to fluconazole. Antimicrobial Agents and Chemotherapy 1995, 39: 1\u20138.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01709586_CR13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/JCM.33.5.1104-1107.1995","volume":"33","author":"MA Pfaller","year":"1995","unstructured":"Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG, Cooper CR, McGinnis MR: Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. Journal of Clinical Microbiology 1995, 33: 1104\u20131107.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JCM.34.3.489-495.1996","volume":"34","author":"MA Ghannoum","year":"1996","unstructured":"Ghannoum MA, Rex JH, Galgiani JN: Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. Journal of Clinical Microbiology 1996, 34: 489\u2013495.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01709586_CR15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1042\/bst0211039","volume":"21","author":"CA Hitchcock","year":"1993","unstructured":"Hitchcock CA: Resistance ofCandida albicans to azole antifungal agents. Biochemical Society Transactions 1993, 21: 1039\u20131047.","journal-title":"Biochemical Society Transactions"},{"key":"BF01709586_CR16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-199550040-00007","volume":"50","author":"KL Goa","year":"1995","unstructured":"Goa KL, Barradell LB: Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs 1995, 50: 658\u2013690.","journal-title":"Drugs"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01709586\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:25:55Z","timestamp":1586287555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01709586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["BF01709586"],"URL":"https:\/\/doi.org\/10.1007\/bf01709586","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}